Adverse drug reactions monitoring to be updated
The Medicines Control Agency is introducing an updated 'yellow card' scheme for reporting suspected adverse drug reactions, designed to protect patient confidentiality. The new scheme will no longer require personal details such as a patient's name and date of birth, but will just ask for information such as a patient's ...
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
- 10 expert briefings every fortnight (Premium only)
Already a subscriber? Sign into your account here